Testing effectiveness (Phase 2)Looking for participantsNCT06589830
What this trial is testing
TL938 and Trastuzumab for Patients With HER2-positive Metastatic Colorectal Cancer
Who this might be right for
Colorectal Cancer MetastaticAdvanced Colorectal Cancer
Suzhou Teligene Ltd. 80